Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases
- PMID: 37331738
- PMCID: PMC10020039
- DOI: 10.1016/j.rdc.2023.03.002
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a delayed postinflammatory disorder associated with the previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially, MIS-C was described as highly similar to Kawasaki disease (KD), a pediatric febrile systemic vasculitis that can lead to the development of coronary artery aneurysms (CAAs). While KD and MIS-C are both inflammatory disorders, the 2 entities differ in their epidemiological, clinical, immunological, and pathological features. MIS-C clinical and laboratory characteristics are more closely related to toxic shock syndrome (TSS) than KD, which informs the understanding of pathogenesis and potential therapeutic approaches.
Keywords: Kawasaki disease; Multisystem inflammatory syndrome in children; SARS-CoV-2; Superantigen; Superantigen-like motif; Toxic shock syndrome.
Copyright © 2023 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.Dermatology. 2022;238(1):35-43. doi: 10.1159/000515449. Epub 2021 Jun 1. Dermatology. 2022. PMID: 34062530 Free PMC article. Review.
-
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.World J Pediatr. 2021 Aug;17(4):335-340. doi: 10.1007/s12519-021-00435-y. Epub 2021 May 20. World J Pediatr. 2021. PMID: 34013488 Free PMC article. Review.
-
Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.BMC Pediatr. 2024 Jul 30;24(1):485. doi: 10.1186/s12887-024-04966-x. BMC Pediatr. 2024. PMID: 39080588 Free PMC article.
-
Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.Physiol Res. 2022 Mar 25;71(1):17-27. doi: 10.33549/physiolres.934672. Epub 2022 Jan 19. Physiol Res. 2022. PMID: 35043641 Free PMC article. Review.
-
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.Rheumatol Int. 2021 Jan;41(1):19-32. doi: 10.1007/s00296-020-04749-4. Epub 2020 Nov 21. Rheumatol Int. 2021. PMID: 33219837 Free PMC article. Review.
Cited by
-
The Central Role of Interleukin-1 Signalling in the Pathogenesis of Kawasaki Disease Vasculitis: Path to Translation.Can J Cardiol. 2024 Dec;40(12):2305-2320. doi: 10.1016/j.cjca.2024.07.023. Epub 2024 Jul 30. Can J Cardiol. 2024. PMID: 39084253 Review.
-
Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C).BMJ Paediatr Open. 2025 Mar 5;9(1):e003148. doi: 10.1136/bmjpo-2024-003148. BMJ Paediatr Open. 2025. PMID: 40044495 Free PMC article.
-
VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes.Life (Basel). 2024 Mar 7;14(3):353. doi: 10.3390/life14030353. Life (Basel). 2024. PMID: 38541678 Free PMC article.
-
Letter to the Editor: "Comparison of Risk Scoring Systems in Predicting Kawasaki Disease Associated Coronary Artery Dilation in a North American Cohort".Pediatr Cardiol. 2024 Dec 24. doi: 10.1007/s00246-024-03754-9. Online ahead of print. Pediatr Cardiol. 2024. PMID: 39718575 No abstract available.
-
Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center Experience.Diagnostics (Basel). 2025 Mar 7;15(6):656. doi: 10.3390/diagnostics15060656. Diagnostics (Basel). 2025. PMID: 40149999 Free PMC article.
References
-
- McCrindle B.W., Rowley A.H., Newburger J.W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous